Kimball Electronics (KE) Q4 FY26 earnings call

Kimball Electronics concluded FY26 with strong cash generation and debt reduction, positioning the company for strategic investments. The Medical segment continues to drive growth, supported by the recent Helvoet acquisition and the build-out of the Indianapolis CDMO facility. While overall sales saw a slight decline, management anticipates a return to organic growth in FY27, led by Medical, with a focus on integrating new assets and leveraging a strengthened balance sheet.